Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliographic Details
Main Author:	Paul, Pulock
Other Authors:	Azam,Faruque
Format:	Thesis
Language:	English
Published:	Brac University 2024
Subjects:	Lung cancer Clinical trial Efficacy endpoints Targeted therapy Lungs > Cancer Clinical trials Chemotherapy
Online Access:	http://hdl.handle.net/10361/23954

Similar Items

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
by: Rahman, Tasnim
Published: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
by: Hoque, Ismoth Ara
Published: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Karim, Samia Binte
Published: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Flora, Sanzida Alam
Published: (2024)

A review on targeted therapies for lung cancer
by: Ashraf, Anushey
Published: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
by: Shobnam, Sohana
Published: (2024)

Molecules associated with the development of lung cancer
by: Rahman, Adree, et al.
Published: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
by: Tania, Umme
Published: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
by: Jeba, Joynob
Published: (2017)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
by: Bristy, Israt Zerin
Published: (2021)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
by: Razna, Amrin Islam
Published: (2019)

Potential of liposomes for the treatment of lung cancer- a review
by: Mim, Shanzida
Published: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
by: Zangmo, Thinley
Published: (2024)

A review on recent advances in drugs for lung cancer treatment
by: Noor, Fouzia
Published: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
by: Hasan, Sakib
Published: (2024)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
by: Akter, Rabia
Published: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
by: Pial, Sazia Afrin
Published: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
by: Shabnam, Musharrat
Published: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
by: Das, Reshita
Published: (2024)

Immunotherapy in the Management of Lung Cancer
by: Tasnim, Humayra
Published: (2022)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
by: Oishy, Jannatun Noor
Published: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
by: Monayem, Kazi Fahim
Published: (2024)

Lung cancer detection and classification using machine learning
by: Arefin, Mahbubul, et al.
Published: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
by: Mukti, Roushney Fatima, et al.
Published: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
by: Nandy, Aditi
Published: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
by: Abir, Shifaty Nur
Published: (2024)

The hidden histories of war crimes trials /

A review on drug repurposing for diabetes epidemic
by: Lamia, Sadia Raisa
Published: (2022)

Update on pharmacological aspects of carotenoids: molecules of pharmaceutical promise
by: Labanna, Marium Akther
Published: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
by: Rahman, Sanjida
Published: (2024)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
by: Ginsburg, Ophira M., et al.
Published: (2018)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
by: Raihan, Dilraj
Published: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
by: F. S. Amaral, André, et al.
Published: (2017)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
by: Nahar, Kamrun
Published: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
by: Auvy, Akib Al Mahmud, et al.
Published: (2023)

Gene therapy for rare genetic disorders
by: Tanjum, Atia
Published: (2024)

Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT‑SHOCK trial
by: Robles‑Zurita, Jose Antonio, et al.
Published: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
by: Sakib, Hasibul, et al.
Published: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
by: Hossain, Safa Binte
Published: (2019)

Targeted therapeutic options in the treatment of Breast Cancer
by: Alam, Kazi Tasnuva
Published: (2022)